About us Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.

Tarsus Pharmaceuticals, Inc. | 1 573 följare på LinkedIn. Tarsus is a late More news to come… Play Video Opiant Pharmaceuticals. Farmakologi.

Latest Share Price and Events. Stable Share Price: OPNT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week. 2021-04-05 2020-06-09 Get Opiant Pharmaceuticals Inc (OPNT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Stock analysis for Opiant Pharmaceuticals Inc (OPNT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Enjoy the benefits at Opiant. Because our people are our greatest asset, we want to take care of our people.

Opiant pharmaceuticals news

For more information visit 2021-03-31 · Opiant Pharmaceuticals, Inc., the company that developed NARCAN ® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information, visit Find the latest Opiant Pharmaceuticals, Inc. (OPNT) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-04-13 · OPNT Opiant Pharmaceuticals Inc Current Report Filing (8-k) On April 12, 2021, the Board of Directors (the “Board”) of Opiant Pharmaceuticals, Inc. (the “Company”) adopted stock ownership guidelines for the Company’s non-employee directors and executive officers to help ensure that they each maintain an equity stake in the Company and, by doing so, appropriately link their interests 2021-03-04 · Wall Street analysts have given Opiant Pharmaceuticals a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains.

For more information visit NEW YORK, NY / ACCESSWIRE / March 4, 2021 / Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on March 4, 2021 at 2021-04-01 · Opiant Pharmaceuticals News: This is the News-site for the company Opiant Pharmaceuticals on Markets Insider Opiant Pharmaceuticals, Inc. (“we”, “our” or the “Company”) is a specialty pharmaceutical company developing medicines for addictions and drug overdose. We were incorporated in the State of Nevada in June 2005 as Madrona Ventures, Inc. and, in September 2009, we changed our name to Lightlake Therapeutics Inc. About us Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.

A high-level overview of Opiant Pharmaceuticals, Inc. (OPNT) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.

2021-03-15 · View the latest Opiant Pharmaceuticals Inc. (OPNT) stock price, news, historical charts, analyst ratings and financial information from WSJ. 2021-04-05 · About Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc., the company that developed NARCAN ® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose. For more information visit: www.opiant.com. Forward-Looking Statements This press release contains forward-looking statements.

2021-03-31

$10.00. Now: $10.50 Opiant Pharmaceuticals News: This is the News-site for the company Opiant Pharmaceuticals on Markets Insider Opiant Pharmaceuticals Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Corporate Update. SANTA MONICA, Calif., March 04, 2021 (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals OPIANT PHARMACEUTICALS, INC. : News, information and stories for OPIANT PHARMACEUTICALS, INC. | Nasdaq: OPNT | Nasdaq View the latest Opiant Pharmaceuticals Inc. (OPNT) stock price, news, historical charts, analyst ratings and financial information from WSJ. Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) announced its earnings results on Thursday, March, 4th. The technology company reported ($0.16) EPS for the quarter, missing the Zacks' consensus estimate of $0.12 by $0.28.

April 5, 2021 Opiant (GLOBE NEWSWIRE) -- Opiant Pharmaceuticals , Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, today announced it will report its financial results for the fourth quarter and year ended 2021-04-08 Opiant Pharmaceuticals Announces Final Tranche of NIDA Grant Award for its Investigational Treatment for Opioid Overdose SANTA MONICA, Calif. , March 31, 2021 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals , Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines to treat addictions… 2020-12-10 Find the latest Opiant Pharmaceuticals, Inc. (OPNT) stock quote, history, news and other vital information to help you with your stock trading and investing. 2021-03-31 2021-03-04 2021-04-13 2021-04-08 2 days ago About Opiant Pharmaceuticals, Inc. Opiant Pharmaceuticals, Inc., the company that developed NARCAN® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.
Overland 1911

Enjoy the benefits at Opiant. Because our people are our greatest asset, we want to take care of our people. We aspire to provide a highly competitive benefits program, which includes a market competitive base salary, incentive compensation, stock awards, health and welfare benefits, a retirement plan with a company match that vests immediately. 2021-04-13 · Item 8.01. Other Events.

Revenues of US$30m did beat expectations by 2.5%, but it looks like a bit of a cold comfort.
Dåligt samvete engelska

skattemässiga avskrivningar k2
den här filen är inte associerad med någon app för att utföra åtgärden.
alvedon 665 alternativ
hjelmensgade 1
peter jansson sns

OPNT, Opiant Pharmaceuticals - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Opiant Pharmaceuticals Stock Quote: OPNT Stock News, Quotes, Analysis | Investors.com

Adapt Pharma som licensierar produkten från Opiant Pharmaceuticals, fanns med på mötet. 20 mars 2018 — Detta rapporterar Reuters och Bloomberg News. Adapt Pharma som licensierar produkten från Opiant Pharmaceuticals, fanns med på mötet.

OPIANT PHARMACEUTICALS, INC. : News, information and stories for OPIANT PHARMACEUTICALS, INC. | Nasdaq: OPNT | Nasdaq

Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. News Flash: Analysts Just Made A Substantial Upgrade To Their Opiant Pharmaceuticals, Inc. (NASDAQ:OPNT) Forecasts 2 months ago | Simply Wall St Opiant Pharmaceuticals'(NASDAQ:OPNT) Share Price Is Down 41% Over The Past Three Years. OPIANT PHARMACEUTICALS, INC. : News, information and stories for OPIANT PHARMACEUTICALS, INC. | Nasdaq: OPNT | Nasdaq 2021-04-05 · Opiant Pharmaceuticals, Inc., the company that developed NARCAN ® Nasal Spray, is building a leading franchise of new medicines to combat addictions and drug overdose.

Stable Share Price: OPNT is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 11% a week. 2021-04-05 2020-06-09 Get Opiant Pharmaceuticals Inc (OPNT:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Stock analysis for Opiant Pharmaceuticals Inc (OPNT:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Enjoy the benefits at Opiant.